Quarterly report pursuant to Section 13 or 15(d)

Net Loss per Share (Details) - Schedule of diluted net loss per share

v3.22.1
Net Loss per Share (Details) - Schedule of diluted net loss per share - shares
3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Total common stock equivalents 1,161,913 881,308
Stock options [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Total common stock equivalents 118,388 118,388
Warrants [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Total common stock equivalents 1,043,525 762,920